Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients

被引:16
作者
Tian, Kaibing [1 ]
Zhang, Haoyu [1 ]
Ma, Junpeng [1 ]
Wang, Ke [1 ]
Ru, Xiaojuan [2 ]
Du, Jiang [3 ]
Jia, Guijun [1 ]
Zhang, Liwei [1 ]
Wu, Zhen [1 ]
Zhang, Junting [1 ]
Wang, Liang [1 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropathol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Chordoma; Overall survival; Prognostic factor; Skull base; Surgery; CRANIOCERVICAL JUNCTION; INTRACRANIAL CHORDOMAS; CLINICAL ARTICLE; TUMOR RECURRENCE; MANAGEMENT; OUTCOMES; PREDICTORS; FEATURES; DISEASE; AGE;
D O I
10.1016/j.wneu.2016.09.055
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Although a controversial and complex issue, the prognostic factors of skull base chordomas are worth exploring. METHODS: Prognostic factors associated with overall survival (OS) were retrospectively estimated in an individual cohort of skull base chordomas prospectively maintained for 10 years by a Kaplan-Meier method and univariate Cox proportional hazards model. Multivariate analysis by Cox regression analysis was performed to identify the independent prognostic factors. A nomogram was then formulated by R software based on the results. RESULTS: A total of 180 primary patients and 45 recurrent cases were included, with a mean follow-up period of 43.7 months (range, 4-127 months). The OS of the primary group at 5 years and 7 years was 84% and 78%, and the mean OS was 103.8 months, which was significantly longer than the recurrent group, in which the mean postrecurrent OS was 68.4 months. In the primary group, preoperative Karnofsky Performance Status (KPS) score (P = 0.004) and a decline of perioperative KPS score (P = 0.015) were identified as independent predictors of OS. A nomogram was contracted to predict 5-year, and 7-year OS, which was well calibrated and had good discriminative ability (adjusted Harrell C statistic, 0.74). In the recurrent group, visual deficit was verified as an independent risk factor associated with postrecurrent OS (P = 0.014). CONCLUSIONS: Both pathologic and perioperative KPS score evaluations are significant in OS prediction of both primary and recurrent cases. The nomogram for primary lesions, consisting of preoperative functional status and its perioperative changes, appears useful for risk stratification of long-term survival.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 50 条
  • [31] Prognostic Factors in Patients With Spinal Chordoma: An Integrative Analysis of 682 Patients
    Zhou, Jianhua
    Sun, James
    Bai, Harrison Xiao
    Huang, Xiangyan
    Zou, Yingjie
    Tan, Xia
    Zhang, Zishu
    Tang, Xiangqi
    Tao, Yongguang
    Xiao, Bo
    Zhang, Paul J.
    Yang, Li
    NEUROSURGERY, 2017, 81 (05) : 812 - 822
  • [32] Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study
    Takagi, Masaru
    Demizu, Yusuke
    Nagano, Fumiko
    Terashima, Kazuki
    Fujii, Osamu
    Jin, Dongcun
    Mima, Masayuki
    Niwa, Yasue
    Katsui, Kuniaki
    Suga, Masaki
    Yamashita, Tomohiro
    Akagi, Takashi
    Sakata, Koh-ichi
    Fuwa, Nobukazu
    Okimoto, Tomoaki
    RADIATION ONCOLOGY, 2018, 13
  • [33] PALB2 as a factor to predict the prognosis of patients with skull base chordoma
    Xiong, Yujia
    Li, Mingxuan
    Shen, Yutao
    Ma, Tianshun
    Bai, Jiwei
    Zhang, Yazhuo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database
    Conti, Catherine
    Pamoukdjian, Frederic
    Aparicio, Thomas
    Mebarki, Soraya
    Poisson, Johanne
    Manceau, Gilles
    Taieb, Julien
    Rance, Bastien
    Katsahian, Sandrine
    Charles-Nelson, Anais
    Paillaud, Elena
    CANCERS, 2022, 14 (05)
  • [35] Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis
    Lee, Ivan J.
    Lee, Robert J.
    Fahim, Daniel K.
    WORLD NEUROSURGERY, 2017, 104 : 346 - 355
  • [36] Factors associated with artificial airway retention after skull base chordoma resection: A retrospective cohort study
    Fu, Yuxuan
    Yu, Yun
    Cui, Yidan
    Wang, Jing
    Ma, Bo
    Jian, Minyu
    Yao, Jingxin
    Jing, Longnian
    Bai, Jiwei
    Han, Ruquan
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [37] High Red Cell Distribution Width Independently Predicts Adverse Survival in Patients with Newly Diagnosed Skull Base Chordoma
    Li, Mingxuan
    Shen, Yutao
    Xiong, Yujia
    Bai, Jiwei
    Wang, Shuai
    Li, Chuzhong
    Zhang, Yazhuo
    ONCOTARGETS AND THERAPY, 2021, 14 : 5435 - 5445
  • [38] Factors influencing overall survival rates for patients with pineocytoma
    Clark, Aaron J.
    Sughrue, Michael E.
    Ivan, Michael E.
    Aranda, Derick
    Rutkowski, Martin J.
    Kane, Ari J.
    Chang, Susan
    Parsa, Andrew T.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (02) : 255 - 260
  • [39] Survival and Recurrence for Patients Undergoing Surgery of Skull Base Intracranial Metastases
    Chaichana, Kaisorn L.
    Flores, Mariana
    Acharya, Shami
    Sampognaro, Paul
    Bettegowda, Chetan
    Rigamonti, Daniele
    Weingart, Jon D.
    Olivi, Alessandro
    Gallia, Gary L.
    Brem, Henry
    Lim, Michael
    Quinones-Hinojosa, Alfredo
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2013, 74 (04) : 228 - 235
  • [40] Impact of Treatment Modalities upon Survival Outcomes in Skull Base and Clival Chordoma: An NCDB Analysis
    Muhonen, Ethan G.
    Yasaka, Tyler M.
    Lehrich, Brandon M.
    Goshtasbi, Khodayar
    Papagiannopoulos, Peter
    Tajudeen, Bobby A.
    St John, Maie A.
    Harris, Jeremy P.
    Hsu, Frank P. K.
    Kuan, Edward C. C.
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2023, 84 (01) : 60 - 68